In vivo-effect of intraadrenal nicotine and substance P application on rat adrenal medullary catecholamine secretion.
The present study was conducted to characterize in vivo the intraadrenal catecholamine (CA) secretion in rats. This was possible by using a microdialysis system (MDS) which mimics some properties of an artificial capillary. One end of this system was connected to a peristaltic pump, from the other end fractions were sampled at 5 min intervals. Concentrations of epinephrine (E) and norepinephrine (NE) in adrenal dialysate fractions were determined by HPLC electrochemical detection. Through this MDS nicotine was administered directly into the adrenal medulla of freely moving rats and the response of catecholamine release was determined. In the second part of the study the effect of exogenous substance P (SP) on spontaneous as well as on nicotine-stimulated CA release was investigated. Like nicotine, SP was administered directly into the adrenal medulla. At a flow rate of 25 microliter/min the transfer rates of CA and nicotine were approximately 1% whereas SP passed at a rate of 01.-0.2%. Under resting conditions CA release remained constant. In response to 2 x 10(-7) M nicotine (which resulted in local concentration of 2 x 10(-7) M), E and NE secretion increased 2.9 and 5.4-fold, respectively. However, due to an increased E response this difference attenuated with a later onset of the first stimulus. The higher concentrations of 10(-4) M resulted in 8.1 and 10.8-fold increases for E and NE. This latter response is clearly supraphysiologic and therefore the 2 x 10(-5) M concentration was used for further experimentation. CA secretion was stimulated with nicotine four times at 30 min intervals.(ABSTRACT TRUNCATED AT 250 WORDS)
Voigt
J P
JP
University of Göttingen, Department of Obstetrics and Gynecology, Germany.
Kaufmann
G
G
Hirsch
B
B
Leonhardt
S
S
Jarry
H
H
Oehme
P
P
Wuttke
W
W
D000311:Adrenal Glands / Q000502:physiology*; D000313:Adrenal Medulla / Q000378:metabolism*; D000818:Animals; D004837:Epinephrine / Q000378:metabolism*; D005260:Female; D017551:Microdialysis; D009538:Nicotine / Q000008:administration & dosage* / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013373:Substance P / Q000008:administration & dosage* / Q000494:pharmacology
D013373:Substance P; D009538:Nicotine; D009638:Norepinephrine; D004837:Epinephrine